Institut Du Cancer De Montpellier - Val D'aurelle

This study tested a combination of two drugs, sorafenib and irinotecan, in 64 adults with advanced colorectal cancer that has a K-RAS mutation and has worsened after prior treatment. The goal was to see if the combination could control the disease. Participants took sorafenib pil…

This phase 2 trial tested a combination of three drugs—gemcitabine, trastuzumab, and erlotinib—as a first treatment for people with metastatic pancreatic cancer. 63 patients received the drugs intravenously and orally. The goal was to see how well the combo controlled the disease…

This study tested whether stronger chemotherapy could help people with colorectal cancer that has spread to the liver and cannot be fully removed by surgery. 124 adults received either standard treatment or one of three stronger drug combinations. The goal was to shrink tumors en…

This study tested a combination of the targeted drug regorafenib with chemotherapy (mGEMOX) in 66 people with advanced bile duct cancer that could not be removed by surgery. The main goal was to find the safest dose and check for side effects. This is not a cure, but aims to cont…

This study tested whether adding sorafenib to irinotecan helps control advanced colorectal cancer with a KRAS mutation. It involved 173 adults whose cancer had worsened after all standard treatments. The goal was to see if the combination slowed tumor growth better than either dr…

This study looked at whether e-health tools—like a phone call from a specialist or a self-report app—can help manage pain and anxiety after a breast biopsy. About 193 women took part. The goal was to see if these check-ins lead to less pain and better well-being compared to stand…

This study tested whether a combination of slow, guided breathing (called cardiac coherence) and a hypnosis session could help women feel less anxious before breast or gynecologic cancer surgery. Fifty-three women participated, practicing the breathing technique several times a d…

This study tested whether a yoga program done at home and in group sessions is practical for breast cancer patients on hormone therapy who have joint pain. 24 patients were asked to follow daily home yoga and attend 6 sessions with a therapist. The goal was to see if patients wou…

This study tracked 146 breast cancer patients receiving standard chemotherapy after surgery. Researchers measured calcium and vitamin levels in blood and urine before, during, and after 6 treatment cycles. The goal was to see how often patients develop high urine calcium (hyperca…

This study looked at spinal fluid from 51 breast cancer patients whose cancer may have spread to the lining of the brain and spinal cord (leptomeningeal metastases). Researchers compared a new blood test technique (CellSearch) with standard spinal fluid analysis to see which bett…

This study looked at whether a blood test measuring how certain immune cells die after radiation can predict long-term side effects in breast and prostate cancer patients. Researchers enrolled 885 participants and tracked late complications. The goal is to personalize treatment t…

This study looked at how cancer affects a type of memory called prospective memory—remembering to do things in the future, like taking medication or keeping appointments. Researchers surveyed 426 people, including those with brain tumors, breast cancer, and healthy volunteers. Th…

This study analyzed tumor and blood samples from 160 people with esophageal or rectal cancer to find genetic markers that might predict how well they respond to chemoradiotherapy before surgery. The goal was to better understand why some patients benefit more than others. No new …

This study followed 26 adults with low-grade glioma who were receiving chemotherapy (temozolomide) for the first time after surgery. Researchers measured how the treatment affected patients' quality of life, thinking skills, and emotional well-being over one year. The goal was to…